Literature DB >> 22566686

Intermolecular binding between TIFA-FHA and TIFA-pT mediates tumor necrosis factor alpha stimulation and NF-κB activation.

Chia-Chi Flora Huang1, Jui-Hung Weng, Tong-You Wade Wei, Pei-Yu Gabriel Wu, Pang-Hung Hsu, Yu-Hou Chen, Shun-Chang Wang, Dongyan Qin, Chin-Chun Hung, Shui-Tsung Chen, Andrew H-J Wang, John Y-J Shyy, Ming-Daw Tsai.   

Abstract

The forkhead-associated (FHA) domain recognizes phosphothreonine (pT) with high specificity and functional diversity. TIFA (TRAF-interacting protein with an FHA domain) is the smallest FHA-containing human protein. Its overexpression was previously suggested to provoke NF-κB activation, yet its exact roles in this signaling pathway and the underlying molecular mechanism remain unclear. Here we identify a novel threonine phosphorylation site on TIFA and show that this phosphorylated threonine (pT) binds with the FHA domain of TIFA, leading to TIFA oligomerization and TIFA-mediated NF-κB activation. Detailed analysis indicated that unphosphorylated TIFA exists as an intrinsic dimer and that the FHA-pT9 binding occurs between different dimers of TIFA. In addition, silencing of endogenous TIFA resulted in attenuation of tumor necrosis factor alpha (TNF-α)-mediated downstream signaling. We therefore propose that the TIFA FHA-pT9 binding provides a previously unidentified link between TNF-α stimulation and NF-κB activation. The intermolecular FHA-pT9 binding between dimers also represents a new mechanism for the FHA domain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566686      PMCID: PMC3416184          DOI: 10.1128/MCB.00438-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway.

Authors:  L Sanz; M T Diaz-Meco; H Nakano; J Moscat
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

2.  Global analysis of modifications of the human BK virus structural proteins by LC-MS/MS.

Authors:  Chiung-Yao Fang; Hsiang-Ying Chen; Meilin Wang; Pei-Lain Chen; Chi-Fang Chang; Li-Sheng Chen; Cheng-Huang Shen; Wei-Chih Ou; Ming-Daw Tsai; Pang-Hung Hsu; Deching Chang
Journal:  Virology       Date:  2010-04-09       Impact factor: 3.616

3.  Structural delineation of MDC1-FHA domain binding with CHK2-pThr68.

Authors:  Hsin-Hui Wu; Pei-Yu Wu; Kai-Fa Huang; Yu-Ya Kao; Ming-Daw Tsai
Journal:  Biochemistry       Date:  2012-01-06       Impact factor: 3.162

4.  Discrete signaling regions in the lymphotoxin-beta receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-kappaB pathways.

Authors:  W R Force; A A Glass; C A Benedict; T C Cheung; J Lama; C F Ware
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

5.  TRAF6 is autoinhibited by an intramolecular interaction which is counteracted by trans-ubiquitination.

Authors:  Kent Z Q Wang; Deborah L Galson; Philip E Auron
Journal:  J Cell Biochem       Date:  2010-06-01       Impact factor: 4.429

6.  Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase.

Authors:  Zhenjian Cai; Nabil H Chehab; Nikola P Pavletich
Journal:  Mol Cell       Date:  2009-09-24       Impact factor: 17.970

7.  Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.

Authors:  Alice C Fan; Debabrita Deb-Basu; Mathias W Orban; Jason R Gotlib; Yasodha Natkunam; Roger O'Neill; Rose-Ann Padua; Liwen Xu; Daryl Taketa; Amy E Shirer; Shelly Beer; Ada X Yee; David W Voehringer; Dean W Felsher
Journal:  Nat Med       Date:  2009-04-12       Impact factor: 53.440

8.  Structural and functional analysis of phosphothreonine-dependent FHA domain interactions.

Authors:  Simon Pennell; Sarah Westcott; Miguel Ortiz-Lombardía; Dony Patel; Jiejin Li; Timothy J Nott; Duaa Mohammed; Roger S Buxton; Michael B Yaffe; Chandra Verma; Stephen J Smerdon
Journal:  Structure       Date:  2010-12-08       Impact factor: 5.006

9.  Structural mechanism of the phosphorylation-dependent dimerization of the MDC1 forkhead-associated domain.

Authors:  Jinping Liu; Shukun Luo; Hongchang Zhao; Ji Liao; Jing Li; Chunying Yang; Bo Xu; David F Stern; Xingzhi Xu; Keqiong Ye
Journal:  Nucleic Acids Res       Date:  2012-01-10       Impact factor: 16.971

10.  The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator.

Authors:  Stephanie Jungmichel; Julie A Clapperton; Janette Lloyd; Flurina J Hari; Christoph Spycher; Lucijana Pavic; Jiejin Li; Lesley F Haire; Mario Bonalli; Dorthe H Larsen; Claudia Lukas; Jiri Lukas; Derek MacMillan; Michael L Nielsen; Manuel Stucki; Stephen J Smerdon
Journal:  Nucleic Acids Res       Date:  2012-01-10       Impact factor: 16.971

View more
  17 in total

1.  TIFA as a crucial mediator for NLRP3 inflammasome.

Authors:  Ting-Yang Lin; Tong-You Wade Wei; Shuai Li; Shen-Chih Wang; Ming He; Marcy Martin; Jiao Zhang; Tzu-Pin Shentu; Han Xiao; Jian Kang; Kuei-Chun Wang; Zhen Chen; Shu Chien; Ming-Daw Tsai; John Y-J Shyy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-13       Impact factor: 11.205

2.  ADP-heptose is a newly identified pathogen-associated molecular pattern of Shigella flexneri.

Authors:  Diego García-Weber; Anne-Sophie Dangeard; Johan Cornil; Linda Thai; Héloïse Rytter; Alla Zamyatina; Laurence A Mulard; Cécile Arrieumerlou
Journal:  EMBO Rep       Date:  2018-11-19       Impact factor: 8.807

3.  TRAF-interacting protein with forkhead-associated domain (TIFA) transduces DNA damage-induced activation of NF-κB.

Authors:  Jingxuan Fu; Daoyuan Huang; Fuwen Yuan; Nan Xie; Qian Li; Xinpei Sun; Xuehong Zhou; Guodong Li; Tanjun Tong; Yu Zhang
Journal:  J Biol Chem       Date:  2018-03-26       Impact factor: 5.157

Review 4.  Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics.

Authors:  Jin-Qiu Chen; Lalage M Wakefield; David J Goldstein
Journal:  J Transl Med       Date:  2015-06-06       Impact factor: 5.531

5.  ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria.

Authors:  Milica Milivojevic; Anne-Sophie Dangeard; Christoph Alexander Kasper; Therese Tschon; Mario Emmenlauer; Claudine Pique; Pamela Schnupf; Julie Guignot; Cécile Arrieumerlou
Journal:  PLoS Pathog       Date:  2017-02-21       Impact factor: 6.823

6.  TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant Hematopoiesis.

Authors:  Madeline Niederkorn; Kathleen Hueneman; Kwangmin Choi; Melinda E Varney; Laurel Romano; Mario A Pujato; Kenneth D Greis; Jun-Ichiro Inoue; Ruhikanta Meetei; Daniel T Starczynowski
Journal:  Cell Rep       Date:  2020-02-25       Impact factor: 9.423

7.  TIFA protein expression is associated with pulmonary arterial hypertension.

Authors:  Hao-Chih Chang; Tong-You Wade Wei; Pei-Yu Wu; Ming-Daw Tsai; Wen-Chung Yu; Chen-Huan Chen; Shih-Hsien Sung
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

8.  Heptose Sounds the Alarm: Innate Sensing of a Bacterial Sugar Stimulates Immunity.

Authors:  Ryan G Gaudet; Scott D Gray-Owen
Journal:  PLoS Pathog       Date:  2016-09-22       Impact factor: 6.823

9.  TIFA, an inflammatory signaling adaptor, is tumor suppressive for liver cancer.

Authors:  W Shen; A Chang; J Wang; W Zhou; R Gao; J Li; Y Xu; X Luo; R Xiang; N Luo; D G Stupack
Journal:  Oncogenesis       Date:  2015-10-26       Impact factor: 7.485

10.  TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways.

Authors:  Wenzhi Shen; Renle Du; Jun Li; Xiaohe Luo; Shuangtao Zhao; Antao Chang; Wei Zhou; Ruifang Gao; Dehong Luo; Juan Wang; Na Hao; Yanhua Liu; Yanan Chen; Yunping Luo; Peiqing Sun; Shengyong Yang; Na Luo; Rong Xiang
Journal:  Signal Transduct Target Ther       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.